Aim: Our aim is to describe a previously unreported potential interaction of nalmefene with methylphenidate and discuss possible mechanisms and precautions. Presentation of Case: A 40-year-old man with ADHD taking long-acting methylphenidate developed alcohol use disorder. Nalmefene was prescribed. Following his first bedtime administration, he awoke with panic attack symptoms and concomitant suicidal and homicidal ideation. These symptoms resolved 45 minutes after he received diazepam. Discussion: Hypotheses for this reaction include a previously undescribed nalmefene–methylphenidate interaction causing elevated levels of either drug and leading to anxiety and panic symptoms, dysphoria, and suicidal/homicidal ideation. ADHD and alcohol a...
INTRODUCTION: Methoxphenidine is a novel dissociative designer drug of the diarylethylamine class wh...
The prescribed use of methylphenidate in the treatment of attention deficit hyperactivity disorder (...
Abstract Methylphenidate is one of the classic amphetamines which can cause or exacerbate psychotic...
BACKGROUND: In this report, we describe a case of a patient with substance-induced anxiety disorder ...
Therapeutic dose of methylphenidate is known to cause adverse effects (psychosis or mania), albeit i...
Item does not contain fulltextImportance: Patients with attention-deficit/hyperactivity disorder (AD...
IMPORTANCE Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk of...
Case: An 18 year old female with no psychiatric history experiences delirium following the administr...
What is known and objective Nalmefene, a new opioid system regulator, has recently been approved for...
BACKGROUND: Serotonin syndrome (SS) is a potentially life-threatening condition that can be caused b...
Abstract Background In this report, we describe a case of a patient with substance-induced anxiety d...
PURPOSE: Substance use disorder often coexists with other psychiatric disorders, resulting in the si...
Attention Deficit and Hyperactivity Disorder (ADHD) is among the most commonly encountered neurodeve...
Purpose: Substance use disorder often coexists with other psychiatric disorders, resulting in the si...
INTRODUCTION: Methoxphenidine is a novel dissociative designer drug of the diarylethylamine class wh...
The prescribed use of methylphenidate in the treatment of attention deficit hyperactivity disorder (...
Abstract Methylphenidate is one of the classic amphetamines which can cause or exacerbate psychotic...
BACKGROUND: In this report, we describe a case of a patient with substance-induced anxiety disorder ...
Therapeutic dose of methylphenidate is known to cause adverse effects (psychosis or mania), albeit i...
Item does not contain fulltextImportance: Patients with attention-deficit/hyperactivity disorder (AD...
IMPORTANCE Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk of...
Case: An 18 year old female with no psychiatric history experiences delirium following the administr...
What is known and objective Nalmefene, a new opioid system regulator, has recently been approved for...
BACKGROUND: Serotonin syndrome (SS) is a potentially life-threatening condition that can be caused b...
Abstract Background In this report, we describe a case of a patient with substance-induced anxiety d...
PURPOSE: Substance use disorder often coexists with other psychiatric disorders, resulting in the si...
Attention Deficit and Hyperactivity Disorder (ADHD) is among the most commonly encountered neurodeve...
Purpose: Substance use disorder often coexists with other psychiatric disorders, resulting in the si...
INTRODUCTION: Methoxphenidine is a novel dissociative designer drug of the diarylethylamine class wh...
The prescribed use of methylphenidate in the treatment of attention deficit hyperactivity disorder (...
Abstract Methylphenidate is one of the classic amphetamines which can cause or exacerbate psychotic...